Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive Patients

A Multi-center, Observational, Cross-sectional Study to Evaluate CVD Risk Factors in Korean Hypertensive Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01362283

Acronym

WONDeR

Enrollment

3109

Registered

2011-05-30

Start date

2010-08-31

Completion date

2011-01-31

Last updated

2016-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The purpose of this study is investigating the proportion of Cardiovascular disease risk factors of hypertensive patients.

Detailed description

Primary endpoint: To evaluate the Proportion of patients with Cardiovascular disease high risk factors Secondary endpoint: To evaluate the Proportion of patients with Cardiovascular disease risk factors, To evaluate the Proportion of patients with Cardiovascular disease, To evaluate Target blood pressure achievement rate according to the proportion of Cardiovascular disease risks

Interventions

OTHERBlood Sampling

Blood sampling for Fasting Plasma Glucose, Hemoglobin A1C, Cholesterols, Blood Urea Nitrogen, Creatinine

Study design

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Essential hypertensive patient no less than 18 yeas old * Patient who gave informed consent form

Exclusion criteria

* Patient was diagnosed as secondary hypertension * Patient who have white-coat hypertension

Design outcomes

Primary

Measure	Time frame	Description
Proportion of patients with cardiovascular disease high risk factors	6years, average duration of hypertension	Between patients with essential hypertension

Secondary

Measure	Time frame	Description
Proportion of patients with Cardiovascular disease risk factors	6years, average duration of hypertension	Between patients with essential hypertension
Proportion of patients with Cardiovascular disease	6years, average duration of hypertension	Between patients with essential hypertension
Target Blood Pressure achievement rate according to the proportion of Cardiovascular disease risks	6years, average duration of hypertension	Between patients with essential hypertension

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026